| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Protein kinase, AMP-activated, alpha 1 catalytic subunit (PRKAA1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY404162 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, AMP-activated, beta 2 non-catalytic subunit (PRKAB2) from ORIGENE TECHNOLOGIES | LY417329 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, AMP-activated, gamma 3 non-catalytic subunit (PRKAG3) from ORIGENE TECHNOLOGIES | LY413786 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, AMP-activated, gamma 1 non-catalytic subunit (PRKAG1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY400962 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, AMP-activated, beta 1 non-catalytic subunit (PRKAB1) from ORIGENE TECHNOLOGIES | LY416773 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, AMP-activated, gamma 2 non-catalytic subunit (PRKAG2), transcript variant c from ORIGENE TECHNOLOGIES | LY421790 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase C, alpha (PRKCA) from ORIGENE TECHNOLOGIES | LY400966 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, cAMP-dependent, catalytic, alpha (PRKACA), transcript variant 1 from ORIGENE TECHNOLOGIES | LY419140 | 100 ug | ORIGENE TECHNOLOGIES |
| Human triggering receptor expressed on myeloid cells-like 2 (TREML2) from ORIGENE TECHNOLOGIES | TP721080 | 10 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, cAMP-dependent, catalytic, beta (PRKACB), transcript variant 2 from ORIGENE TECHNOLOGIES | LY419141 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, cAMP-dependent, catalytic, alpha (PRKACA), transcript variant 2 from ORIGENE TECHNOLOGIES | LY403918 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, cAMP-dependent, catalytic, gamma (PRKACG) from ORIGENE TECHNOLOGIES | LY419142 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase (cAMP-dependent, catalytic) inhibitor alpha (PKIA), transcript variant 6 from ORIGENE TECHNOLOGIES | LY402041 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, cAMP-dependent, catalytic, beta (PRKACB), transcript variant 3 from ORIGENE TECHNOLOGIES | LY403923 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase (cAMP-dependent, catalytic) inhibitor alpha (PKIA), transcript variant 7 from ORIGENE TECHNOLOGIES | LY405612 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase (cAMP-dependent, catalytic) inhibitor alpha (PKIA), transcript variant 7 from ORIGENE TECHNOLOGIES | LY430578 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase (cAMP-dependent, catalytic) inhibitor beta (PKIB), transcript variant 1 from ORIGENE TECHNOLOGIES | LY405588 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase (cAMP-dependent, catalytic) inhibitor beta (PKIB), transcript variant 2 from ORIGENE TECHNOLOGIES | LY430565 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase (cAMP-dependent, catalytic) inhibitor beta (PKIB), transcript variant 3 from ORIGENE TECHNOLOGIES | LY410103 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase (cAMP-dependent, catalytic) inhibitor gamma (PKIG), transcript variant 1 from ORIGENE TECHNOLOGIES | LY405596 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase (cAMP-dependent, catalytic) inhibitor gamma (PKIG), transcript variant 1 from ORIGENE TECHNOLOGIES | LY430570 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase (cAMP-dependent, catalytic) inhibitor gamma (PKIG), transcript variant 2 from ORIGENE TECHNOLOGIES | LY416230 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase (cAMP-dependent, catalytic) inhibitor gamma (PKIG), transcript variant 3 from ORIGENE TECHNOLOGIES | LY405595 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase (cAMP-dependent, catalytic) inhibitor gamma (PKIG), transcript variant 3 from ORIGENE TECHNOLOGIES | LY430569 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) (PRKAR1A), transcript variant 1 from ORIGENE TECHNOLOGIES | LY400963 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) (PRKAR1A), transcript variant 2 from ORIGENE TECHNOLOGIES | LY403944 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) (PRKAR1A), transcript variant 2 from ORIGENE TECHNOLOGIES | LY431006 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) (PRKAR1A), transcript variant 3 from ORIGENE TECHNOLOGIES | LY403945 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, cAMP-dependent, regulatory, type I, beta (PRKAR1B), transcript variant 1 from ORIGENE TECHNOLOGIES | LY431891 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, cAMP-dependent, regulatory, type I, beta (PRKAR1B), transcript variant 2 from ORIGENE TECHNOLOGIES | LY400964 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, cAMP-dependent, regulatory, type I, beta (PRKAR1B), transcript variant 3 from ORIGENE TECHNOLOGIES | LY431887 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, cAMP-dependent, regulatory, type I, beta (PRKAR1B), transcript variant 4 from ORIGENE TECHNOLOGIES | LY431888 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, cAMP-dependent, regulatory, type I, beta (PRKAR1B), transcript variant 5 from ORIGENE TECHNOLOGIES | LY431889 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, cAMP-dependent, regulatory, type I, beta (PRKAR1B), transcript variant 6 from ORIGENE TECHNOLOGIES | LY431890 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, cAMP-dependent, regulatory, type II, alpha (PRKAR2A) from ORIGENE TECHNOLOGIES | LY401337 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, cAMP-dependent, regulatory, type II, beta (PRKAR2B) from ORIGENE TECHNOLOGIES | LY419138 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase C and casein kinase substrate in neurons 1 (PACSIN1) from ORIGENE TECHNOLOGIES | LY412198 | 100 ug | ORIGENE TECHNOLOGIES |
| Protein kinase, AMP-activated, gamma 2 non-catalytic subunit (PRKAG2), transcript variant a from ORIGENE TECHNOLOGIES | LY402518 | 100 ug | ORIGENE TECHNOLOGIES |
| Human tripartite motif-containing 21 (TRIM21) from ORIGENE TECHNOLOGIES | TP302088 | 20 ug | ORIGENE TECHNOLOGIES |
| Protein kinase C and casein kinase substrate in neurons 2 (PACSIN2) from ORIGENE TECHNOLOGIES | LY416115 | 100 ug | ORIGENE TECHNOLOGIES |
| Human tripartite motif-containing 26 (TRIM26) from ORIGENE TECHNOLOGIES | TP302881 | 20 ug | ORIGENE TECHNOLOGIES |
| Human tripartite motif-containing 25 (TRIM25) from ORIGENE TECHNOLOGIES | TP303757 | 20 ug | ORIGENE TECHNOLOGIES |
| Human tripartite motif-containing 28 (TRIM28) from ORIGENE TECHNOLOGIES | TP301205 | 20 ug | ORIGENE TECHNOLOGIES |
| Human tripartite motif-containing 29 (TRIM29) from ORIGENE TECHNOLOGIES | TP301916 | 20 ug | ORIGENE TECHNOLOGIES |
| Human tripartite motif-containing 31 (TRIM31) from ORIGENE TECHNOLOGIES | TP301930 | 20 ug | ORIGENE TECHNOLOGIES |
| Human tripartite motif-containing 44 (TRIM44) from ORIGENE TECHNOLOGIES | TP301074 | 20 ug | ORIGENE TECHNOLOGIES |
| Protein kinase (cAMP-dependent, catalytic) inhibitor beta (PKIB), transcript variant 2 from ORIGENE TECHNOLOGIES | LY405587 | 100 ug | ORIGENE TECHNOLOGIES |
| Human tripartite motif-containing 47 (TRIM47) from ORIGENE TECHNOLOGIES | TP318521 | 20 ug | ORIGENE TECHNOLOGIES |
| Human tripartite motif-containing 58 (TRIM58) from ORIGENE TECHNOLOGIES | TP317706 | 20 ug | ORIGENE TECHNOLOGIES |
| Human tripartite motif-containing 68 (TRIM68) from ORIGENE TECHNOLOGIES | TP317536 | 20 ug | ORIGENE TECHNOLOGIES |